WHITNEY SIMS: Open Payments
NPI 1073161634 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 26 payments from 14 companies in 2025. Trend: 2023 $677 · 2024 $1,290 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| PFIZER INC. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Corcept Therapeutics | 2 | $49 |
| Impulse Dynamics (USA) Inc. | 1 | $30 |
| ABIOMED | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Amgen Inc. | 1 | $22 |
Products named: LOKELMA, JARDIANCE, LEQVIO, ELIQUIS, Korlym, Optimizer, Kerendia, CAMZYOS.
Industry payments across SC — which companies pay providers there.
